Skip to main content
Clinical Trials/ITMCTR2100005237
ITMCTR2100005237
Recruiting
Phase 1

To study the infrared thermal imaging characteristics of insomnia, mild cognitive impairment, depression and subthreshold depression based on the holistic view of Traditional Chinese Medicine

Shenzhen Hospital of Beijing University of Traditional Chinese Medicine (Longgang)0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Insomnia, depression, subthreshold depression, mild cognitive impairment
Sponsor
Shenzhen Hospital of Beijing University of Traditional Chinese Medicine (Longgang)
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Shenzhen Hospital of Beijing University of Traditional Chinese Medicine (Longgang)

Eligibility Criteria

Inclusion Criteria

  • 1\. Insomnia inclusion criteria:
  • (1\) Meet the diagnostic criteria of western medicine for insomnia;
  • (2\) Aged 18\-80 years;
  • (3\) Consciousness, clear thinking, and use of language to communicate;
  • (4\) Pittsburgh Sleep Quality Index \> 5;
  • (5\) The subjects voluntarily participate in the clinical trial and sign the informed consent form, and the procedure meets the requirements of GCP.
  • 2\. Depression included in the case criteria:
  • (1\) Meet the diagnostic criteria for depression;
  • (2\) Gender is not limited, aged \>\= 18 year;
  • (3\) Able to independently complete the questionnaire, give informed consent and participate voluntarily.

Exclusion Criteria

  • 1\. Exclusion criteria for insomnia cases:
  • (1\) All systemic diseases such as pain, fever, cough, surgery, etc., as well as insomnia caused by external environmental interference factors;
  • (2\) Severe mental illness that affects sleep, such as: schizophrenia, bipolar disorder, paranoid disorder, schizoaffective disorder, mental disorder caused by epilepsy, and severe mental retardation;
  • (3\) Those who are pregnant, breastfeeding and those who plan to become pregnant;
  • (4\) Those who are allergic to aromatic drugs or have a history of severe adverse reactions, and those with severe allergic constitution;
  • (5\) Those with other serious diseases of the circulatory system, hematopoietic system, digestive system, endocrine system, etc.;
  • (6\) Those who are participating in clinical trials of other drugs.
  • 2\. Subthreshold depression and exclusion criteria for depression:
  • (1\) Patients with previous psychotic disorder or organic mental disorder;
  • (2\) Depressive episodes caused by psychoactive substances and non\-addictive substances;

Outcomes

Primary Outcomes

Not specified

Similar Trials